1. Market Research
  2. > Pharmaceutical
  3. > Generic Drug Market Trends
  4. > World Generic Markets 20 OCTOBER 2014

World Generic Markets 20 OCTOBER 2014

  • October 2014
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Leaked TPP Document Reveals Pharmaceutical Policy Disputes Remain
Industry Brief - Impax To Acquire Tower Holdings And Subsidiaries
Industry Trend Analysis - Congress Probes Generic Drug Pricing
Industry Brief - Synthon Files Glatiramer ANDA With FDA
Industry Brief - Sucampo Settles US Amitiza Litigation; Receives New Challenger
Industry Brief - New Generic Threat To Trokendi XR Revealed
Industry Brief - Breckenridge Launches Mefanamic Acid In US
Industry Brief - Noven Files Paroxetine Lawsuit Against Actavis
Industry Brief - Actavis Initiates Methylphenidate Patent Challenge
Industry Trend Analysis - WHO BQ Proposal Gains Traction, But EGA Response Delivers Stumbling Block
Industry Brief - STADA In-Licenses Biosimilar Teriparatide
Industry Trend Analysis - USTR Initiates India Review In A Changed Political Landscape
Industry Brief - Cipla Bolsters Presence In Kenya
Industry Brief - Cipla Medpro Teams Up With Teva In South Africa
Industry Trend Analysis - Stalled Patent Reforms Would Increase Access To Essential Medicines

Table Of Contents

World Generic Markets 20 OCTOBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...

The Future of Generic Drugs and Strategies for Commercial Success

The Future of Generic Drugs and Strategies for Commercial Success

  • $ 2995
  • Industry report
  • September 2016
  • by CBR Pharma Insights

The Future of Generic Drugs and Strategies for Commercial Success Summary GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.